Robert A. Bonomo

60.5k total citations · 18 hit papers
723 papers, 39.8k citations indexed

About

Robert A. Bonomo is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Robert A. Bonomo has authored 723 papers receiving a total of 39.8k indexed citations (citations by other indexed papers that have themselves been cited), including 562 papers in Molecular Medicine, 242 papers in Pharmacology and 219 papers in Epidemiology. Recurrent topics in Robert A. Bonomo's work include Antibiotic Resistance in Bacteria (562 papers), Antibiotics Pharmacokinetics and Efficacy (231 papers) and Vibrio bacteria research studies (109 papers). Robert A. Bonomo is often cited by papers focused on Antibiotic Resistance in Bacteria (562 papers), Antibiotics Pharmacokinetics and Efficacy (231 papers) and Vibrio bacteria research studies (109 papers). Robert A. Bonomo collaborates with scholars based in United States, Argentina and Italy. Robert A. Bonomo's co-authors include David L. Paterson, Andrea M. Hujer, Krisztina M. Papp‐Wallace, Sarah M. Drawz, David van Duin, Federico Pérez, Kristine M. Hujer, Andrea Endimiani, Magdalena A. Taracila and Michael R. Jacobs and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Robert A. Bonomo

696 papers receiving 38.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extended-Spectrum β-Lactamases: a Clinical Update

2005 2.6k citations David L. Paterson, Robert A. Bonomo profile →
Three Decades of β-Lactamase Inhibitors

2010 1.3k citations Robert A. Bonomo et al. profile →
Carbapenems: Past, Present, and Future

2011 1.1k citations Krisztina M. Papp‐Wallace, Andrea Endimiani et al. Antimicrobial Agents and Chemotherapy profile →
Global Challenge of Multidrug-ResistantAcinetobacter baumannii

2007 973 citations Federico Pérez, Andrea M. Hujer et al. Antimicrobial Agents and Chemotherapy profile →
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges

2017 828 citations Travis B. Nielsen, Robert A. Bonomo et al. profile →
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa

2006 568 citations Robert A. Bonomo et al. Clinical Infectious Diseases profile →
10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

2013 555 citations Robert A. Bonomo et al. Clinical Infectious Diseases profile →
Effect of Antibiotic Therapy on the Density of Vancomycin-Resistant Enterococci in the Stool of Colonized Patients

2000 510 citations Curtis J. Donskey, Andrea M. Hujer et al. profile →
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

2017 479 citations David van Duin, Eric Cober et al. Clinical Infectious Diseases profile →
Better Tests, Better Care: Improved Diagnostics for Infectious Diseases

2013 461 citations Fred C. Tenover, Robert A. Bonomo et al. Clinical Infectious Diseases profile →
Carbapenemase-Producing Organisms: A Global Scourge

2017 422 citations Robert A. Bonomo et al. Clinical Infectious Diseases profile →
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations

2016 417 citations David van Duin, Robert A. Bonomo Clinical Infectious Diseases profile →
Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding

2014 410 citations Liang Chen, Robert A. Bonomo et al. profile →
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

2023 402 citations Pranita D. Tamma, Robert A. Bonomo et al. Clinical Infectious Diseases profile →
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-ResistantAcinetobacter baumannii, andStenotrophomonas maltophiliaInfections

2021 333 citations Pranita D. Tamma, Robert A. Bonomo et al. Clinical Infectious Diseases profile →
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

2020 310 citations Pranita D. Tamma, Robert A. Bonomo et al. Clinical Infectious Diseases profile →
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

2022 308 citations Pranita D. Tamma, Robert A. Bonomo et al. Clinical Infectious Diseases profile →
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), andPseudomonas aeruginosawith Difficult-to-Treat Resistance (DTR-P. aeruginosa)

2021 303 citations Pranita D. Tamma, Robert A. Bonomo et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Robert A. Bonomo

Since Specialization

Citations

This map shows the geographic impact of Robert A. Bonomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Bonomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Bonomo more than expected).

Fields of papers citing papers by Robert A. Bonomo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Bonomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Bonomo. The network helps show where Robert A. Bonomo may publish in the future.

Co-authorship network of co-authors of Robert A. Bonomo

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Bonomo. A scholar is included among the top collaborators of Robert A. Bonomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Bonomo. Robert A. Bonomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic insights of two Acinetobacter non-baumannii strains with uncommon mechanisms of resistance leading to cefiderocol resistance 2025 ·Infection Genetics and Evolution ·(unknown), (unknown), (unknown), Juan Pablo Gutiérrez, Fernando Pasterán, Marisel R. Tuttobene, (unknown), Jerry C. Cheng, (unknown), Rajnikant Sharma, Marcelo E. Tolmasky, Gauri G. Rao, Robert A. Bonomo, Germán M. Traglia, María Soledad	0
2	Cefepime-Taniborbactam—a Novel Combination Therapy for Multidrug-Resistant Pathogens 2025 ·The Journal of Infectious Diseases ·Richard Watkins, Tracy L. Lemonovich, Alejandro J. Vila, Robert A. Bonomo	2
3	Impact of tebipenem pivoxil on the intestinal microbiota and on establishment of colonization with carbapenem-resistant Klebsiella pneumoniae in mice 2025 ·Microbiology Spectrum ·María F. Mojica, (unknown), (unknown), (unknown), Brigid Wilson, (unknown), Cecilia Saiz, Graciela Mahler, Alejandro J. Vila, Naseer Sangwan, Curtis J. Donskey, Robert A. Bonomo	1
4	2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Utility of Blood Cultures in Adults, Children, and Pregnant People 2024 ·Clinical Infectious Diseases ·Robert A. Bonomo, Romney M. Humphries, Fredrick M. Abrahamian, Mary Bessesen, Anthony W. Chow, E. Patchen Dellinger, Morven S. Edwards, Ellie J. C. Goldstein, Mary K. Hayden, Keith S. Kaye, Brian A. Potoski, Jesús Rodríguez‐Baño, Robert G. Sawyer, Marion Skalweit, David R. Snydman, Pranita D. Tamma, Sarah Pahlke, (unknown), (unknown)	7
5	Insights into Acinetobacter baumannii AMA205’s Unprecedented Antibiotic Resistance 2024 ·International Journal of Molecular Sciences ·Germán M. Traglia, Fernando Pasterán, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marisel R. Tuttobene, (unknown), C. Ferro Fontán, Ezequiel Albornoz, (unknown), Robert A. Bonomo, Gauri G. Rao, Marcelo E. Tolmasky, María Soledad Ramírez	2
6	Increased mortality in hospital- compared to community-onset carbapenem-resistant enterobacterales infections 2024 ·Journal of Antimicrobial Chemotherapy ·Angelique E Boutzoukas, Natalie A Mackow, (unknown), Lauren Komarow, Carol Hill, Liang Chen, Yohei Doi, Michael J. Satlin, César A. Arias, Minggui Wang, (unknown), Erica Herc, Eric Cober, Gregory Weston, Robin Patel, Robert A. Bonomo, Vance G. Fowler, David van Duin	2
7	Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus 2024 ·mBio ·Khalid M Dousa, (unknown), Sebastian G. Kurz, Mark S. Plummer, (unknown), Christopher R. Bethel, (unknown), (unknown), (unknown), Charles L. Daley, Kenneth E. Remy, Steven M. Holland, Robert A. Bonomo	10
8	Carbapenem-resistant Enterobacterales in solid organ transplant recipients 2024 ·American Journal of Transplantation ·Angelique E Boutzoukas, (unknown), Eric Cober, Lilian M. Abbo, Lauren Komarow, Liang Chen, Carol Hill, Michael J. Satlin, Matthew Grant, Bettina C. Fries, Gopi Patel, Todd P McCarty, César A. Arias, Robert A. Bonomo, David van Duin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
9	Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam 2023 ·mBio ·Andrea M. Hujer, Steven H. Marshall, Andrew R Mack, Kristine M. Hujer, Yamuna Devi Bakthavatchalam, (unknown), (unknown), (unknown), Prashant Joshi, Rahul Shrivastava, Hariharan Periasamy, Sachin Bhagwat, Mahesh Patel, Balaji Veeraraghavan, Robert A. Bonomo	11
10	Tixagevimab/cilgavimab for preventing COVID-19 during the Omicron surge: retrospective analysis of National Veterans Health Administration electronic data 2023 ·mBio ·Yinong Young‐Xu, Lauren Epstein, Vincent C. Marconi, Victoria J. Davey, Caroline Korves, (unknown), Jeremy Smith, Fran Cunningham, Robert A. Bonomo, Adit A. Ginde	12
11	Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action 2022 ·mBio ·Khalid M Dousa, (unknown), Sebastian G. Kurz, Magdalena A. Taracila, Christopher R. Bethel, (unknown), Barry N. Kreiswirth, Sheldon T. Brown, W. Henry Boom, Richard S. Hotchkiss, Kenneth E. Remy, Frank J. Jacono, Charles L. Daley, Steven M. Holland, Alita A. Miller, Robert A. Bonomo	30
12	Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits 2022 ·Antimicrobial Agents and Chemotherapy ·Vidmantas Petraitis, Rūta Petraitienė, Povilas Kavaliauskas, (unknown), Andrew Garcia, (unknown), Roger Echols, Robert A. Bonomo, Yoshinori Yamano, Michael J. Satlin, Thomas J. Walsh	14
13	The H-NS Regulator Plays a Role in the Stress Induced by Carbapenemase Expression in Acinetobacter baumannii 2020 ·mSphere ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Carolina López, Lisandro J. González, Rodrigo Sieira, Alejandro J. Vila, Robert A. Bonomo, María Soledad Ramírez	12
14	Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates 2017 ·Antimicrobial Agents and Chemotherapy ·Bartolomé Moyá, Isabel M. Barceló, Sachin Bhagwat, Mahesh Patel, Germán Bou, Krisztina M. Papp‐Wallace, Robert A. Bonomo, Antonio Oliver	66
15	Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE 2017 ·mBio ·Travis B. Nielsen, Paul Pantapalangkoor, Jun Yan, Brian Luna, (unknown), Kevin W. Bruhn, Brandon Tan, (unknown), Robert A. Bonomo, Ann Marie Schmidt, Michael P. Everson, Frederick P. Duncanson, Terence M. Doherty, Lin Lin, Brad Spellberg	48
16	Carbapenem-Resistant Enterobactercloacae in Patients from the US Veterans Health Administration, 2006–2015 2017 ·Emerging infectious diseases ·Brigid Wilson, Nadim G. El Chakhtoura, Sachin Patel, Elie Saade, Curtis J. Donskey, Robert A. Bonomo, Federico Pérez	53
17	Emergence of Linezolid-Resistant Staphylococcus aureus after Prolonged Treatment of Cystic Fibrosis Patients in Cleveland, Ohio 2011 ·Antimicrobial Agents and Chemotherapy ·Andrea Endimiani, (unknown), Elliott C. Dasenbrook, Michael D. Reed, (unknown), Andrea M. Hujer, Susan D. Rudin, Kristine M. Hujer, Vincent Perreten, Louis B. Rice, Michael R. Jacobs, Michael W. Konstan, Robert A. Bonomo	76
18	Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae 2010 ·Antimicrobial Agents and Chemotherapy ·Brandon Kitchel, J. Kamile Rasheed, Andrea Endimiani, Andrea M. Hujer, Karen Anderson, Robert A. Bonomo, Jean B. Patel	128
19	Presence of Plasmid-Mediated Quinolone Resistance in Klebsiella pneumoniae Isolates Possessing bla _KPC in the United States 2008 ·Antimicrobial Agents and Chemotherapy ·Andrea Endimiani, Lenore L. Carias, Andrea M. Hujer, Christopher R. Bethel, Kristine M. Hujer, Federico Pérez, Rebecca A. Hutton, W. Fox, Geraldine S. Hall, Michael R. Jacobs, David L. Paterson, Louis B. Rice, Stephen G. Jenkins, Fred C. Tenover, Robert A. Bonomo	83
20	Spread in an Italian Hospital of a Clonal Acinetobacter baumannii Strain Producing the TEM-92 Extended-Spectrum β-Lactamase 2007 ·Antimicrobial Agents and Chemotherapy ·Andrea Endimiani, Francesco Luzzaro, Roberta Migliavacca, Elisabetta Mantengoli, Andrea M. Hujer, Kristine M. Hujer, Laura Pagani, Robert A. Bonomo, Gian María Rossolini, Antonio Toniolo	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact